Pharmacokinetics of thiopental and pentobarbital enantiomers after intravenous administration of racemic thiopental

Anesthesia and Analgesia

Volumn 83, Issue 3, 1996, Pages 552-558

  Nguyen, Khai T ^a   Stephens, Dianne P ^b   McLeish, Michael J ^a   Crankshaw, David P ^b   Morgan, Denis J ^a  

^a MONASH UNIVERSITY   (Australia)

^b ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

PENTOBARBITAL; THIOPENTAL;

ADULT; AGED; ARTICLE; DRUG BLOOD LEVEL; DRUG POTENCY; GENERAL ANESTHESIA; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; NORMAL HUMAN; PLASMA CLEARANCE; PRIORITY JOURNAL; STEREOCHEMISTRY;

EID: 0029838492     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-199609000-00020     Document Type: Article

References (17)

1. Fragen RJ, Avram MJ. Barbiturates in anesthesia. In: Miller RD, ed. Anesthesia. New York: Churchill Livingstone, 1990:225-42.
2. Morgan DJ. Intravenous anaesthetics: thiopentone and related compounds. In: Damani LA, ed. Sulphur drugs and related organic chemicals. Chichester, UK: Ellis Horwood Ltd, 1989: 89-120.
3. Buhrer M, Maitre PO, Hung OR, et al. Thiopental pharmacodynamics. I. Defining the pseudo-steady-state serum concentration-EEG effect relationship. Anesthesiology 1992;77:226-36.
4. Hung OR, Varvel JR, Shafer SL, Stanski DR. Thiopental pharmacodynamics. II. Quantitation of clinical and electroencephalographic depth of anesthesia. Anesthesiology 1992;77:237-44.
5. Shanks CA, Avram MJ, Krejcie TC, et al. A pharmacokinetic- pharmacodynamic model for quantal responses with thiopental. J Pharmacokinet Biopharm 1993;21:309-21.
6. Chan HN, Morgan DJ, Crankshaw DP, Boyd MD. Pentobarbitone formation during thiopentone infusion. Anaesthesia 1985; 40:1155-9.
7. Cook CE, Seltzman TB, Tallent CR, et al. Pharmacokinetics of pentobarbital enantiomers as determined by enantioselective radioimmunoassay after administration of racemate to humans and rabbits. J Pharmacol Exp Ther 1987;241:779-85.
8. Crankshaw DP, Boyd MD, Bjorksten AR. Plasma drug efflux - a new approach to optimization of drug infusion for constant blood concentration of thiopental and methohexital. Anesthesiology 1987;67:32-41.
9. Morgan DJ, Blackman GL, Paull JD, Wolf LJ. Pharmacokinetics and plasma binding of thiopental. I. Studies in surgical patients. Anesthesiology 1981;54:468-73.
10. Jones DJ, Nguyen KT, McLeish MJ, et al. Determination of (R)-(+)- and (S)-(-)-isomers of thiopentone in plasma by chiral high-performance liquid chromatography. J Chromatogr 1996; 675:174-9.
11. Gibaldi M, Perrier D. Pharmacokinetics. New York: Marcel Dekker, 1982.
12. Wilkinson GR. Clearance approaches in pharmacology. Pharmacol Rev 1987;39:1-47.
13. Burch PG, Stanski DR. The role of metabolism and protein binding in thiopental anesthesia. Anesthesiology 1983;58: 146-52.
14. Tucker GT, Lennard MS. Enantiomer specific pharmacokinetics. Pharmacol Ther 1990;45:309-29.
15. Svensson CK, Woodruff MN, Baxter JG, Lalka D. Free drug concentration monitoring in clinical practice. Rationale and current status. Clin Pharmacokinet 1986;11:450-69.
16. Ariens EJ. Stereochemistry, a basis for sophisticated nonsense in pharmacokinetics and clinical pharmacology. Eur J Clin Pharmacol 1984;26:663-8.
17. Bruce DA, Gennarelli TA, Langfitt TW. Resuscitation from coma due to head injury. Crit Care Med 1978;6:254-69.